PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

Abroad (travel likely)RecruitingPHASE2

Conditions

TNBC - Triple-Negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut Jules Bordet, Brussels, Belgium
Contact: Study coordinator (Loubna Taraji Schiltz) · loubna.taraji@hubruxelles.be

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

TNBC · TNBC - Triple-Negative Breast Cancer · Early Stage Triple-Negative Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Los Angeles, United States

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Advanced Solid Tumor · Advanced Malignant Neoplasm · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Irvine, United States · La Jolla, United States

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Triple Negative Breast Cancer · Breast Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Orange, United States

Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

TNBC · Brain Metastasis

Abroad (travel likely)RecruitingPHASE2

Shanghai, China